{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-001785","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2026-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.545946+00:00","generated_at":"2026-05-16T11:29:36.170055+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"China Pharma Holdings shareholders approve reverse stock split up to 1:20 at annual meeting","bullets":["Elected independent directors Gene Michael Bennett, Yingwen Zhang, Baowen Dong (3,500,418+ votes for each).","Approved reverse stock split up to 1:20 (3,500,256 for, 780 against); Board has discretion on timing.","Approved Amendment No.3 to the Amended and Restated 2010 Long-Term Incentive Plan (3,500,258 for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-001785","json":"https://secwatch.observer/filing/0001213900-26-001785.json","markdown":"https://secwatch.observer/filing/0001213900-26-001785.md","text":"https://secwatch.observer/filing/0001213900-26-001785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390026001785/0001213900-26-001785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390026001785/ea0271960-8k_chinapharm.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:29:36.170055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}